Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 481K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Amack, J. D. Articles by Mahadevan, M. S. Search for Related Content PubMed PubMed Citation Articles by Amack, J. D. Articles by Mahadevan, M. S. Social Bookmarking                            What's this?

© The Rockefeller University Press, 0021-9525/2002/11/419 $5.00
The Journal of Cell Biology, Volume 159, Number 3, 419-429

Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD

Laboratory of Genetics, University of Wisconsin-Madison, Madison, WI 53706

Address correspondence to Mani S. Mahadevan, University of Virginia, P.O. Box 800904, Charlottesville, VA 22908. Tel.: (434) 243-4816. Fax: (434) 924-1545. E-mail: mahadevan{at}virginia.edu

Myotonic dystrophy (DM) is caused by two similar noncoding repeat expansion mutations (DM1 and DM2). It is thought that both mutations produce pathogenic RNA molecules that accumulate in nuclear foci. The DM1 mutation is a CTG expansion in the 3' untranslated region (3'-UTR) of dystrophia myotonica protein kinase (DMPK). In a cell culture model, mutant transcripts containing a (CUG)₂₀₀ DMPK 3'-UTR disrupt C2C12 myoblast differentiation; a phenotype similar to what is observed in myoblast cultures derived from DM1 patient muscle. Here, we have used our cell culture model to investigate how the mutant 3'-UTR RNA disrupts differentiation. We show that MyoD protein levels are compromised in cells that express mutant DMPK 3'-UTR transcripts. MyoD, a transcription factor required for the differentiation of myoblasts during muscle regeneration, activates differentiation-specific genes by binding E-boxes. MyoD levels are significantly reduced in myoblasts expressing the mutant 3'-UTR RNA within the first 6 h under differentiation conditions. This reduction correlates with blunted E-box–mediated gene expression at time points that are critical for initiating differentiation. Importantly, restoring MyoD levels rescues the differentiation defect. We conclude that mutant DMPK 3'-UTR transcripts disrupt myoblast differentiation by reducing MyoD levels below a threshold required to activate the differentiation program.

Key Words: myotonic dystrophy; trinucleotide repeats; differentiation; MyoD; muscle development

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Margolis, J. M., Schoser, B. G., Moseley, M. L., Day, J. W., Ranum, L. P.W. (2006). DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum Mol Genet 15: 1808-1815 [Abstract] [Full Text]  
• Sun, L., Trausch-Azar, J. S., Ciechanover, A., Schwartz, A. L. (2005). Ubiquitin-Proteasome-mediated Degradation, Intracellular Localization, and Protein Synthesis of MyoD and Id1 during Muscle Differentiation. J. Biol. Chem. 280: 26448-26456 [Abstract] [Full Text]  
• Kino, Y., Mori, D., Oma, Y., Takeshita, Y., Sasagawa, N., Ishiura, S. (2004). Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Hum Mol Genet 13: 495-507 [Abstract] [Full Text]  
• Sobczak, K., de Mezer, M., Michlewski, G., Krol, J., Krzyzosiak, W. J. (2003). RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res 31: 5469-5482 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents